-
公开(公告)号：US20220317117A1
公开(公告)日：2022-10-06
申请号：US17705311
申请日：2022-03-26
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: G01N33/543 , B01L3/00 , B01L7/00
Abstract: The present invention provides a system and method for building and optimizing biosensors to create a multi-layered bio-sensing system by incorporating two different formats comprised of i) a single wall carbon tubular sensing element and ii) a non-tubular graphene sensing element. This multi-layered system allows for assaying molecules across a large range of molecular weights by sensing molecules in both gas and liquid from a common sample simultaneously. By collecting and analyzing both larger, heavier molecules, including, but not limited to: proteins hormones, nucleic acids, lipids, lipoproteins, etc., with non-tubular graphene sensors and smaller, lighter volatile organic compounds (VOCs) as emitted in gas form from the same sample are assayed with single walled-carbon nanotubules (SWNTs), this invention provides a more complete, holistic understanding of the organism's current state of health.
-
公开(公告)号：US20220175694A1
公开(公告)日：2022-06-09
申请号：US17676486
申请日：2022-02-21
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: A61K31/05 , A61K36/185 , A61K31/568 , A61P5/00 , A23K20/184 , A23K20/158 , A23K10/30 , A23K20/111 , A23K50/40
Abstract: The present invention discloses a system and method for improving the quality of life in canines and other domesticated animals. As animals age testosterone and other supportive hormones diminish causing reduced activity, a lack of mobility, decreased bone density, and general well-being. Precursor compositions are selected and designed for the purpose of formulating non-toxic therapeutic hormone supplements for oral consumption. The process and method of this invention is comprised of therapies produced from two or more selected non-toxic prohormones that combine during digestion and delivered through a chewable and edible gummy treat. As such there is no requirement for changing the subject's current diet. The present invention features a continuous low dose supplementation to be incorporated daily whereby dosages are correlated according to the subject's age, weight, sex, and breed. The beneficial results of the present invention are achieved through the absorption of the prohormones in the composition into the bloodstream effecting delivery to all cells including those specific cells where the conversion enzymes are activated by the organism's needs. The delivery and transport of inactive prohormones minimizes liver toxicity since the precursors are carried through the hepatic portal system to and through the liver and into general circulation in inactive forms.
-
公开(公告)号：US20210228502A1
公开(公告)日：2021-07-29
申请号：US17227320
申请日：2021-04-11
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: A61K31/05 , A61K31/566 , A61K31/192 , A61K31/085 , A61K31/352 , A23K20/184 , A23K20/121 , A23K20/111
Abstract: The present invention discloses a system and method for preparing and delivering various precursor compositions as a replacement therapy for testosterone and other hormone deficiencies that naturally occur with aging in canines and other domesticated animals. Precursor compositions are selected and designed for the purpose of formulating non-toxic therapeutic hormone supplement for oral consumption. The invention features low dose continuous supplementation to be incorporated with daily meals. The process of the present invention delivers an orally ingested substance, e.g., a food, supplement, treat, etc., that contains an anti-aging formulation comprising a hormone precursor (prohormone) that is absorbed by the digestive system and secreted into the bloodstream with a second substance to facitate its ingestion, absorption and delivery to the body's tissues.
-
公开(公告)号：US20210181212A1
公开(公告)日：2021-06-17
申请号：US17187880
申请日：2021-03-01
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: G01N33/84 , G01N33/497
Abstract: The present invention describes a non-invasive system and method for detecting early stage Alzheimer's and other autoimmune diseases associated with neurological deficits, including Multiple Sclerosis and Parkinson's Disease. By analyzing the volatile organic compounds (VOCs) found in the otic canal either in gaseous form or as what is commonly known as “earwax”, the current invention discloses how these disease signatures/profiles are illustrative of the presence or absence of a particular disease.
-
公开(公告)号：US20200311755A1
公开(公告)日：2020-10-01
申请号：US16781076
申请日：2020-02-04
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: G06Q30/02 , G06Q50/00 , H04L29/08 , H04L29/06 , G06F16/9535
Abstract: A method of and system for enabling users to manage and control access to and utilization of the data that is collected by web sites, social networks and the like regarding their online and offline interactions, and operating a rewards-based social network wherein rewards are issued by a third party to a member of the social network in exchange for providing access to that online interaction profile data of the member and their networked members, wherein the profile and/or rewards may be stored in one or more records in a blockchain ledger. The rewards may take the form of a cryptocurrency, cash currency, reward points and miles, store credits, bartered goods and services, micro-bits, and the like. Users can manage their profile, and accordingly the compensation they receive from third parties for access to their profile, through a dashboard interface accessible on the web.
-
Patent Agency Ranking
46.发明申请公开(公告)号：US20200074868A1
公开(公告)日：2020-03-05
申请号：US16435696
申请日：2019-06-10
Applicant: Richard Postrel
Inventor： Richard Postrel
Abstract: A drone traffic management system comprising a computer comprising memory means for storing origin coordinates indicating an origin location of a drone, destination coordinates indicating a destination of the drone, and traffic management factors located between the origin location of the drone and the destination of the drone; and processing means for controlling the flight of a drone. This is accomplished by calculating a flight path for the drone to fly automatically from the origin location to the destination location without manual intervention, sending the flight path to the drone, receiving location data of the drone as it travels from the origin location to the destination, re-calculating the flight path of the drone as a function of the traffic management factors and the location data of the drone, and sending the re-calculated flight path to the drone.
-
47.发明申请公开(公告)号：US20200024615A1
公开(公告)日：2020-01-23
申请号：US16041785
申请日：2018-07-21
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: C12N15/86 , A61P35/00 , C12N15/113
Abstract: This invention teaches systems and methods for identifying, targeting and destroying cancer cells with a cell-killing vector attracted to signature elements common to most cancer cells. As cells progress from a normal to a cancerous state their accelerated metabolic rates and adapted pathways generate excess amounts of H+ (resulting in a locally reduced pH) along with a higher heat signature that can serve as a targeting beacon for a specialized cell killing vectors such as a virus and/or a liposome. The cancer cell's heat/pH signature in large part is due to the cell's decreased reliance on mitochondria and the mitochondrial electron transport chain. A lactate overload built up using the alternative ATP generation pathway must be excreted by the cell. Co-transport of H+/lactate is accomplished mainly through a mono-carboxylate transporter 4 protein (MCT4). The present invention while using the pH/heat signature as a delivery adjunct increases targeted killing effectiveness by improving the cell killer vector targeting with a protein capable of binding MCT4. The higher concentration of vector in contact with the targeted cells enhances the heat and pH associated delivery of lethal agents.
-
公开(公告)号：US20190275270A1
公开(公告)日：2019-09-12
申请号：US15913983
申请日：2018-03-07
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: A61M15/00 , A61K9/00 , A61M11/08 , A61K31/352
Abstract: A system and method for treating acute migraine events utilizing multiple sensory/receptive channels (olfactory, audio, visual and other sensory receptors) to both treat and optimize delivery to the afflicted sites in the brain. One of the primary migraine treatment methods includes a composition delivered through the olfactory system. Absorption through the nasal membranes is rapid and avoids delays and dilution inherent in methods using the mouth and gastro-intestinal (GI) processing. Effective, but less preferred methods that avoid GI delays and dilution include delivery as eyedrops or as an intravenous infusion. The effective composition comprises a caffeinic substance to bind and antagonize adenosine receptors in the brain. This immediately blocks continued action of adenosine to dilate the afflicted vessels and inflict pain. The composition also incorporates cannabinolic substances which work simultaneously or in parallel using the body's natural endocannabinoid pathways to rebalance and control blood flow to minimize swelling and pain. Additional features may incorporate additional active components. One available feature may incorporate a recipient/patient control modulus where the patient adjusts treatment using a feedback device such as a stimulation button to increase or adjust delivery. Another additional feature comprises one or more essential oils. Although some essential oil compositions may themselves include one or more compounds that contribute to the desired cannabinolic effects, adding essential oils even those lacking an inherent cannabinolic effect can contribute to effective treatment. Fragrant inclusions in an essential oil additive may provide a calming stimulation to the olfactory system that supports reduced tension and relaxation and thereby removes a tension induced exacerbation of migraine progression.
-
49.发明申请公开(公告)号：US20190134228A1
公开(公告)日：2019-05-09
申请号：US15808563
申请日：2017-11-09
Applicant: Richard Postrel
Inventor： Richard Postrel
IPC: A61K49/00 , A61K9/50 , A61K35/763 , A61K35/761 , A61K35/765 , A61K35/76 , C12N15/113 , A61K38/02
Abstract: This invention provides tools and methods that prevent a cancer cell from growing and reproducing more cancer cells. When growth ceases the body's immune defenses are enabled to attack and destroy these cells if the cancer cell itself has not initiated its own natural apoptotic self-destruction processes. The tools and methods of the invention obstruct the metabolic adaptions required to support cancer growth. By addressing the increased rates of metabolism characteristic of all rapidly reproducing cancer cells using chemical and/or physical nanotechnology to identify, segregate, isolate these hypermetabolizing cells, the body's immune system and other natural defenses are empowered to further isolate and eliminate the diseased cells. The extreme growth rates required for their rapid reproduction involve massively increased rates of the biochemical reactions supporting the cancerous growth. Each excess reaction produces extra heat and raises the internal cell's temperature and the tissue space immediate to the rapidly growing cells. This heat signature is used as a primary biomarker that enables binding of a nanoviral particle engineered to migrate to at attach at the target site at the site and prevent the cell from continued metabolism. Preferably, the nanoparticle not only binds and blocks external membrane receptors on the target cell, but incorporates into the rapidly metabolizing cells additional metabolic blocking agents to stop their growth. When cell growth and proliferation are stopped, the body's natural defenses are able to segregate and eliminate these cells. The massively increased rates of metabolic reactions characteristic of cancer cells also produce excess acid. The decreased pH is useful as a secondary or confirmatory marker for identifying these cancer cells.
-
公开(公告)号：US20190114685A1
公开(公告)日：2019-04-18
申请号：US15783045
申请日：2017-10-13
Applicant: Richard Postrel
Inventor： Richard Postrel
Abstract: A method and system for dispensing a product having a controlled substance. A dispensing system receives a request input to obtain the product from the dispensing system. The dispensing system reads an identification card encoded with user identification. A biometric data input device obtains biometric data from the user, and then a user verification process is executed using the user identification and the obtained biometric data. If the user verification process fails, then the user is informed that access to the product is denied. If, however, the user verification process passes, a product accessibility determination is executed. If the product accessibility determination fails, then the user is informed that access to the product is denied. If, however, the product accessibility determination passes, then a measurement process is executed and a payment process is executed to obtain payment for the measured product, and the product is dispensed to the user.
-
-
-
-
-
-
-
-
-
Search Results
219
records
(took 0.032 seconds)
